FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40015611000001105: Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Sep 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2000321000001113 Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2000341000001115 Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Is a Mometasone + Olopatadine true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Nasal route true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Has specific active ingredient Mometasone furoate true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspensionspray.nasal ontology form and route true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Olopatadine true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Has specific active ingredient Olopatadine hydrochloride true Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd) Is a True Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Inferred relationship Existential restriction modifier
Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray 240 dose Has VMP True Mometasone 25micrograms/dose / Olopatadine 600micrograms/dose nasal spray Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start